To mark the 50th Anniversary of the International Organization for Medical Physics (IOMP), national and regional medical physics organizations were invited to nominate medical physicists, who have made an outstanding contribution to the advancement of medical physics and healthcare through research, clinical developments, education and training activities, service development, and to professional matters over the last 50 years.
Wolfgang Schlegel is known for his pioneering work in radiotherapy physics. Under his leadership new technologies for radiotherapy were developed, which significantly enhanced the precision and effectiveness of cancer treatment with ionizing radiation. Wolfgang Schlegel studied Physics in Berlin and Heidelberg and was a graduate student at the Max-Planck-Institute for Nuclear Physics in Heidelberg where he graduated in 1970 and received the Ph.D. (Dr. rer. nat.) in 1972.
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.